Stonebridge Capital Management Inc. Raises Holdings in DENTSPLY SIRONA Inc (XRAY)

Stonebridge Capital Management Inc. boosted its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 16.7% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 142,781 shares of the medical instruments supplier’s stock after acquiring an additional 20,480 shares during the quarter. DENTSPLY SIRONA comprises about 2.3% of Stonebridge Capital Management Inc.’s portfolio, making the stock its 14th largest position. Stonebridge Capital Management Inc. owned about 0.06% of DENTSPLY SIRONA worth $6,413,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. DnB Asset Management AS lifted its holdings in shares of DENTSPLY SIRONA by 7.4% in the 2nd quarter. DnB Asset Management AS now owns 26,004 shares of the medical instruments supplier’s stock valued at $1,138,000 after buying an additional 1,800 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $1,371,000. Suntrust Banks Inc. lifted its holdings in shares of DENTSPLY SIRONA by 35.8% in the 1st quarter. Suntrust Banks Inc. now owns 10,492 shares of the medical instruments supplier’s stock valued at $526,000 after buying an additional 2,765 shares during the period. Polar Asset Management Partners Inc. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $14,746,000. Finally, Xact Kapitalforvaltning AB lifted its holdings in shares of DENTSPLY SIRONA by 6.6% in the 1st quarter. Xact Kapitalforvaltning AB now owns 37,800 shares of the medical instruments supplier’s stock valued at $1,902,000 after buying an additional 2,330 shares during the period. 93.81% of the stock is owned by institutional investors.

In other DENTSPLY SIRONA news, Director Michael J. Coleman sold 6,038 shares of the business’s stock in a transaction that occurred on Friday, June 1st. The stock was sold at an average price of $43.97, for a total transaction of $265,490.86. Following the completion of the sale, the director now directly owns 26,960 shares in the company, valued at approximately $1,185,431.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Nicholas W. Alexos acquired 50,000 shares of the business’s stock in a transaction on Wednesday, May 9th. The shares were purchased at an average price of $44.71 per share, with a total value of $2,235,500.00. Following the completion of the purchase, the chief financial officer now owns 25,411 shares in the company, valued at approximately $1,136,125.81. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 7,856 shares of company stock valued at $349,153. 1.93% of the stock is owned by company insiders.

Shares of DENTSPLY SIRONA stock traded up $0.57 on Friday, hitting $45.48. The company’s stock had a trading volume of 79,256 shares, compared to its average volume of 2,366,973. The company has a quick ratio of 1.46, a current ratio of 2.23 and a debt-to-equity ratio of 0.25. DENTSPLY SIRONA Inc has a 1 year low of $41.64 and a 1 year high of $68.98. The firm has a market cap of $10.13 billion, a PE ratio of 17.08, a P/E/G ratio of 2.31 and a beta of 1.23.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.03. DENTSPLY SIRONA had a positive return on equity of 8.63% and a negative net margin of 38.32%. The firm had revenue of $956.10 million during the quarter, compared to analyst estimates of $942.20 million. During the same quarter in the previous year, the business earned $0.49 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 6.2% compared to the same quarter last year. sell-side analysts expect that DENTSPLY SIRONA Inc will post 2.57 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.35 annualized dividend and a yield of 0.77%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 13.16%.

Several equities analysts have recently issued reports on the company. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Friday. Barclays reissued a “hold” rating and issued a $55.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, May 8th. ValuEngine cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Robert W. Baird decreased their price objective on DENTSPLY SIRONA to $71.00 and set an “outperform” rating for the company in a report on Tuesday, May 8th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $57.00 price target (down previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, May 8th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $62.23.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply